187 related articles for article (PubMed ID: 32677669)
1. Fibrinogen is a promising biomarker for chronic obstructive pulmonary disease: evidence from a meta-analysis.
Zhou B; Liu S; He D; Wang K; Wang Y; Yang T; Zhang Q; Zhang Z; Niu W
Biosci Rep; 2020 Jul; 40(7):. PubMed ID: 32677669
[TBL] [Abstract][Full Text] [Related]
2. Inflammatory biomarkers and exacerbations in chronic obstructive pulmonary disease.
Thomsen M; Ingebrigtsen TS; Marott JL; Dahl M; Lange P; Vestbo J; Nordestgaard BG
JAMA; 2013 Jun; 309(22):2353-61. PubMed ID: 23757083
[TBL] [Abstract][Full Text] [Related]
3. The clinical value of suPAR in diagnosis and prediction for patients with chronic obstructive pulmonary disease: a systematic review and meta-analysis.
Huang Q; Xiong H; Shuai T; Wang Y; Zhang C; Zhang M; Zhu L; Lu J; Liu J
Ther Adv Respir Dis; 2020; 14():1753466620938546. PubMed ID: 32643535
[TBL] [Abstract][Full Text] [Related]
4. Blood fibrinogen as a biomarker of chronic obstructive pulmonary disease.
Duvoix A; Dickens J; Haq I; Mannino D; Miller B; Tal-Singer R; Lomas DA
Thorax; 2013 Jul; 68(7):670-6. PubMed ID: 22744884
[TBL] [Abstract][Full Text] [Related]
5. Fibrinogen, chronic obstructive pulmonary disease (COPD) and outcomes in two United States cohorts.
Valvi D; Mannino DM; Müllerova H; Tal-Singer R
Int J Chron Obstruct Pulmon Dis; 2012; 7():173-82. PubMed ID: 22419864
[TBL] [Abstract][Full Text] [Related]
6. Growth Differentiation Factor-15 Is a Novel Biomarker Predicting Acute Exacerbation of Chronic Obstructive Pulmonary Disease.
Mutlu LC; Altintas N; Aydin M; Tulubas F; Oran M; Kucukyalin V; Kaplan G; Gurel A
Inflammation; 2015 Oct; 38(5):1805-13. PubMed ID: 25820390
[TBL] [Abstract][Full Text] [Related]
7. Clinical Phenotypes, Comorbidities, and Exacerbations according to Serum 25-OH Vitamin D and Plasma Fibrinogen Levels in Chronic Obstructive Pulmonary Disease.
Hyun DG; Oh YM; Lee SW; Lee SD; Lee JS
J Korean Med Sci; 2019 Jul; 34(29):e195. PubMed ID: 31347309
[TBL] [Abstract][Full Text] [Related]
8. Soluble urokinase-type plasminogen activator receptor as a measure of treatment response in acute exacerbation of COPD.
AboEl-Magd GH; Mabrouk MM
J Bras Pneumol; 2018; 44(1):36-41. PubMed ID: 29538541
[TBL] [Abstract][Full Text] [Related]
9. A correlational meta-analytical study of transforming growth factor-β genetic polymorphisms as a risk factor for chronic obstructive pulmonary disease.
He D; Li J; Zhou B; Chen Y; Hui Q; Ye F; Zhang L; He X; Niu W; Zhang Q
Gene; 2020 Jun; 744():144633. PubMed ID: 32240778
[TBL] [Abstract][Full Text] [Related]
10. Fibrinogen, COPD and mortality in a nationally representative U.S. cohort.
Mannino DM; Valvi D; Mullerova H; Tal-Singer R
COPD; 2012 Aug; 9(4):359-66. PubMed ID: 22489912
[TBL] [Abstract][Full Text] [Related]
11. Platelet Count and Platelet Indices in Patients with Stable and Acute Exacerbation of Chronic Obstructive Pulmonary Disease: A Systematic Review and Meta-Analysis.
Zinellu A; Paliogiannis P; Sotgiu E; Mellino S; Fois AG; Carru C; Mangoni AA
COPD; 2021 Apr; 18(2):231-245. PubMed ID: 33929925
[TBL] [Abstract][Full Text] [Related]
12. Microalbuminuria, von Willebrand factor and fibrinogen levels as markers of the severity in COPD exacerbation.
Polatli M; Cakir A; Cildag O; Bolaman AZ; Yenisey C; Yenicerioglu Y
J Thromb Thrombolysis; 2008 Oct; 26(2):97-102. PubMed ID: 17622488
[TBL] [Abstract][Full Text] [Related]
13. Beclometasone for chronic obstructive pulmonary disease.
De Coster DA; Jones M; Thakrar N
Cochrane Database Syst Rev; 2013 Oct; (10):CD009769. PubMed ID: 24105424
[TBL] [Abstract][Full Text] [Related]
14. Fibrinogen, a Promising Marker to Evaluate Severity and Prognosis of Acute Exacerbation of Chronic Obstructive Pulmonary Disease: A Retrospective Observational Study.
Sun W; Cao Z; Ma Y; Wang J; Zhang L; Luo Z
Int J Chron Obstruct Pulmon Dis; 2022; 17():1299-1310. PubMed ID: 35686213
[TBL] [Abstract][Full Text] [Related]
15. Type IV collagen turnover is predictive of mortality in COPD: a comparison to fibrinogen in a prospective analysis of the ECLIPSE cohort.
Rønnow SR; Sand JMB; Langholm LL; Manon-Jensen T; Karsdal MA; Tal-Singer R; Miller BE; Vestbo J; Leeming DJ
Respir Res; 2019 Apr; 20(1):63. PubMed ID: 30935391
[TBL] [Abstract][Full Text] [Related]
16. Correlation of CRP and serum level of fibrinogen with severity of disease in chronic obstructive pulmonary disease patients.
Lazovic B
Med Arch; 2012; 66(3):159-60. PubMed ID: 22822613
[TBL] [Abstract][Full Text] [Related]
17. Serum Surfactant Protein D is a Potential Biomarker for Chronic Obstructive Pulmonary Disease: a Systematic Review and Meta-analysis.
Wang H; Li F; Huang H; Wu F; Chen L; Zhang D; Zhang T; Wan Y
Clin Lab; 2019 Dec; 65(12):. PubMed ID: 31850711
[TBL] [Abstract][Full Text] [Related]
18. End-product of fibrinogen is elevated in emphysematous chronic obstructive pulmonary disease and is predictive of mortality in the ECLIPSE cohort.
Manon-Jensen T; Langholm LL; Rønnow SR; Karsdal MA; Tal-Singer R; Vestbo J; Leeming DJ; Miller BE; Bülow Sand JM
Respir Med; 2019; 160():105814. PubMed ID: 31739246
[TBL] [Abstract][Full Text] [Related]
19. Long noncoding RNAs antisense noncoding RNA in the INK4 locus (ANRIL) correlates with lower acute exacerbation risk, decreased inflammatory cytokines, and mild GOLD stage in patients with chronic obstructive pulmonary disease.
Ge J; Geng S; Jiang H
J Clin Lab Anal; 2019 Feb; 33(2):e22678. PubMed ID: 30230590
[TBL] [Abstract][Full Text] [Related]
20. Vasoactive Intestinal Peptide for Diagnosing Exacerbation in Chronic Obstructive Pulmonary Disease.
Mandal J; Roth M; Costa L; Boeck L; Rakic J; Scherr A; Tamm M; Stolz D
Respiration; 2015; 90(5):357-68. PubMed ID: 26447811
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
